SLI
2.000,28
PKT
-10,46
PKT
-0,52
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.11.15 | Novartis Hold | Deutsche Bank AG | |
| 30.11.15 | Roche buy | Deutsche Bank AG | |
| 30.11.15 | Holcim Outperform | Credit Suisse Group | |
| 30.11.15 | Givaudan buy | Goldman Sachs Group Inc. | |
| 30.11.15 | ABB (Asea Brown Boveri) kaufen | HSBC | |
| 26.11.15 | UBS kaufen | S&P Capital IQ | |
| 26.11.15 | Richemont buy | HSBC | |
| 26.11.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 26.11.15 | Holcim overweight | JP Morgan Chase & Co. | |
| 26.11.15 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 26.11.15 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.11.15 | Holcim Sell | Société Générale Group S.A. (SG) | |
| 26.11.15 | Holcim buy | Deutsche Bank AG | |
| 26.11.15 | UBS Neutral | UBS AG | |
| 25.11.15 | Richemont buy | Citigroup Corp. | |
| 25.11.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 25.11.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.11.15 | UBS overweight | Morgan Stanley | |
| 25.11.15 | Swiss Re buy | HSBC | |
| 24.11.15 | UBS Halten | Independent Research GmbH | |
| 24.11.15 | Holcim buy | Goldman Sachs Group Inc. | |
| 24.11.15 | UBS overweight | Barclays Capital | |
| 24.11.15 | Holcim overweight | JP Morgan Chase & Co. | |
| 24.11.15 | UBS Neutral | JP Morgan Chase & Co. | |
| 24.11.15 | UBS overweight | JP Morgan Chase & Co. | |
| 24.11.15 | Richemont buy | Nomura | |
| 24.11.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 23.11.15 | Nestlé Underperform | BNP PARIBAS | |
| 23.11.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 23.11.15 | UBS Neutral | Goldman Sachs Group Inc. | |
| 20.11.15 | Holcim buy | Kepler Cheuvreux | |
| 19.11.15 | Swiss Re overweight | Morgan Stanley | |
| 19.11.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 18.11.15 | Holcim Hold | Baader Wertpapierhandelsbank | |
| 17.11.15 | Richemont overweight | Morgan Stanley | |
| 16.11.15 | Zurich Insurance Equal-Weight | Morgan Stanley | |
| 13.11.15 | Roche overweight | Morgan Stanley | |
| 12.11.15 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 11.11.15 | Givaudan Neutral | UBS AG | |
| 11.11.15 | Novartis neutral | Morgan Stanley |